Sol─Gel enters six exclusive license agreements to commercialize Twyneo and Epsolay in Europe & South Africa
Sol-Gel Technologies, Ltd., a dermatology company, has entered into six (6) exclusive license agreements with MagnaPharm Trading Slovakia S.R.L, Galenica A.B, Leman SKL SA, InfectoPharm, Aspire Pharma Limited and Abex Pharmaceutica (PTY) Ltd. for the …